DK1135514T3 - E1b-deleteret adenovirale shuttle-vektorer - Google Patents

E1b-deleteret adenovirale shuttle-vektorer

Info

Publication number
DK1135514T3
DK1135514T3 DK00907050T DK00907050T DK1135514T3 DK 1135514 T3 DK1135514 T3 DK 1135514T3 DK 00907050 T DK00907050 T DK 00907050T DK 00907050 T DK00907050 T DK 00907050T DK 1135514 T3 DK1135514 T3 DK 1135514T3
Authority
DK
Denmark
Prior art keywords
shuttle vectors
gene
deleted adenoviral
adenoviral shuttle
treatment
Prior art date
Application number
DK00907050T
Other languages
Danish (da)
English (en)
Inventor
Terry Hermiston
Julie Nye
Original Assignee
Onyx Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharma Inc filed Critical Onyx Pharma Inc
Application granted granted Critical
Publication of DK1135514T3 publication Critical patent/DK1135514T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Image Generation (AREA)
  • Image Processing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radar Systems Or Details Thereof (AREA)
DK00907050T 1999-01-28 2000-01-26 E1b-deleteret adenovirale shuttle-vektorer DK1135514T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11781499P 1999-01-28 1999-01-28
PCT/US2000/002029 WO2000044922A1 (en) 1999-01-28 2000-01-26 E1b-deleted adenoviral shuttle vectors

Publications (1)

Publication Number Publication Date
DK1135514T3 true DK1135514T3 (da) 2009-09-07

Family

ID=22374975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00907050T DK1135514T3 (da) 1999-01-28 2000-01-26 E1b-deleteret adenovirale shuttle-vektorer

Country Status (10)

Country Link
EP (1) EP1135514B1 (pt)
AT (1) ATE431421T1 (pt)
AU (1) AU772544B2 (pt)
CA (1) CA2360355A1 (pt)
CY (1) CY1109288T1 (pt)
DE (1) DE60042196D1 (pt)
DK (1) DK1135514T3 (pt)
ES (1) ES2325303T3 (pt)
PT (1) PT1135514E (pt)
WO (1) WO2000044922A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
CA2474777A1 (en) * 2002-02-01 2003-08-07 Transgene S.A. Adenoviral vectors for modulating the cellular activities associated with pods
PT2403951E (pt) 2009-03-02 2016-01-29 Univ California Mutantes de adenovírus e1a e e1b de tumores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5981275A (en) * 1997-04-14 1999-11-09 Genzyme Corporation Transgene expression system for increased persistence

Also Published As

Publication number Publication date
CY1109288T1 (el) 2014-07-02
AU772544B2 (en) 2004-04-29
WO2000044922A1 (en) 2000-08-03
ATE431421T1 (de) 2009-05-15
AU2861300A (en) 2000-08-18
EP1135514B1 (en) 2009-05-13
ES2325303T3 (es) 2009-09-01
PT1135514E (pt) 2009-07-20
DE60042196D1 (de) 2009-06-25
EP1135514A1 (en) 2001-09-26
CA2360355A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
PT797676E (pt) Vector adenoviral recombinante e metodos de utilizacao
NO950939D0 (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
DK0836648T3 (da) Rekombinant MVA-virus og anvendelse deraf
EP0710288A4 (en) ADENOVIRAL VECTORS FOR TREATMENT OF HEMOPHILIA
KR970706806A (ko) 신규한 아데노바이러스성 벡터, 패키징 세포주, 재조합 아데노바이러스와 그 방법(novel adenoviral vectors, packagning cell lines, recombinant adenoviruses and methods)
IS4762A (is) Samfallandi eitlaveiru genaferjukerfi og frumulínur
ATE295853T1 (de) Langes pentraxin ptx3 enthaltende pharmazeutische zusammensetzungen
CY1109288T1 (el) Αδενοϊικοι φορεις οχηματα με απαλοιφη ε1β
HUP9802587A2 (hu) Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek
DE60237013D1 (de) Replizierende adenovirus-vektoren
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
DK1224310T3 (da) Fremstilling af rekombinante adenovira og adenovirale banker
WO2000029573A3 (en) Adenoviral vectors
WO2000022136A3 (en) Recombinant e1a deleted adenoviral vectors
酒井佳夫 Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with α-fetoprotein promoter and Cre/lox P system
UA70909C2 (uk) Рекомбінантний аденовірусний вектор, фармацевтична композиція, що його містить, та набір для зменшення проліферації пухлинних клітин
BR0009666A (pt) Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1
WO2003031633A3 (de) Adenovirales vektorsystem
MY157873A (en) Recombinant mva virus, and the use thereof
MY134484A (en) Recombinant mva virus, and the use thereof
MY119381A (en) Recombinant mva virus, and the use thereof